1P-LSD (as well as other LSD analogs) may have therapeutic and medicinal health benefits when used in clinical human trials, according to researchers. A recent study funded by The Beckley Foundation and Imperial College in London, England became the first ever human study to use 1P-LSD, our top-selling product, as a treatment in psychotherapy (Garner).
In an article published by The Guardian, journalist Rosalind Stone described her experience with 1P-LSD as “my favourite trip […] warmth spreads through you like syrup. Words will be more fun to say. […] It’s difficult to choose what to look at: colours bleed smoke trails beyond edges of objects, like the “fountains of colour” described by LSD discoverer Albert Hofmann in 1943.” (Stone)
A report from Wired Magazine revealed that 1P-LSD is commonly used as a microdosing supplement in Silicon Valley (Solon).
In the year 2015, Vice Magazine awarded 1P-LSD the title of “most innovative drug” of the year (Meulenbeld).
Garner, Courtney. “LSD Microdosing: Is It a Placebo or Does It Improve Cognition Function and Wellbeing?” SciTech Europa, 3 Sept. 2018, www.scitecheuropa.eu/lsd-microdosing-placebo-study/88841/.
Stone, Rosalind. “What Does an LSD-Style Drug-Induced ‘Higher State of Consciousness’ Feel like?” The Guardian, Guardian News and Media, 20 Apr. 2017, www.theguardian.com/science/2017/apr/20/what-does-an-lsd-style-drug-induced-higher-state-of-consciousness-feel-like.
Solon, Olivia. Under Pressure, Silicon Valley Workers Turn to LSD Microdosing. 21 May 2019, www.wired.co.uk/article/lsd-microdosing-drugs-silicon-valley.
Meulenbeld, David. Deze Designerdrugs Hebben 2015 Gewonnen. 27 Dec. 2015, www.vice.com/be/article/exyypk/deze-designerdrugs-hebben-2015-gewonnen-394.